Research article
Simultaneous detection of α-Lactoalbumin, β-Lactoglobulin and Lactoferrin in milk by Visualized Microarray
Published on: 12 September 2017
Call for papers: Role of Synthetic Biology and Gene Engineering in CAR Immunotherapy
BMC Biotechnology is currently accepting submissions to a thematic series entitled ' Role of Synthetic Biology and Gene Engineering in CAR Immunotherapy'.
Chimeric antigen receptor (CAR) T cells therapies, as a cancer immunotherapy, have provided significant benefit in treating cancer.
To present the recent advances in the theory and application of CAR immunotherapy, we invite you and/or members of your research team to provide a manuscript for this thematic series.
Your submission could take the form of original research, review, or commentary.
Deadline for submission to the collection: 30th June 2018
The molecular engineering of chimeric T cell receptors opens a window onto interactions bet ween a cytotoxic T cell and a cancer cell with exciting implications for immunotherapy.
Articles
-
-
Research article
-
Research article
-
Methodology article
A split ubiquitin system to reveal topology and released peptides of membrane proteins
Published on: 2 September 2017
-
Research article
Expression of Vitreoscilla hemoglobin enhances production of arachidonic acid and lipids in Mortierella alpina
Published on: 30 August 2017
-
Methodology article
An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol
Published on: 4 December 2008
-
Methodology article
FastCloning: a highly simplified, purification-free, sequence- and ligation-independent PCR cloning method
Published on: 12 October 2011
-
Research article
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
Published on: 26 June 2013
-
Methodology article
Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells
Published on: 12 November 2013
-
Methodology article
Aims and scope
BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.
Editor
- Ying Lou, BioMed Central
Section Editors
- Ayelet Fishman,Technion
- Joaquim M Cabral, Instituto Superior Tecnico
- Dennis Claessen, Leiden University
- Peter J Punt, TNO Microbiology & Systems Biology/Leiden University
- Marko Radic, University of Tennessee
- John J Rossi, Beckman Research Institute City of Hope
- Igor Stagljar, University of Toronto
- Neal C Stewart, University of Tennessee
Data Support Services pilot
Authors submitting to this journal can opt to use a new service that will make it easier to share research data.
BMC Series blog
View feed-
Behind the Image: a bug’s life
Published on: 15 September 2017
-
Socio-economic disadvantage and cancer survival disparities
Published on: 14 September 2017
-
The Martian had a lot of problems. Anemia probably wasn’t one of them.
Published on: 12 September 2017
Advertisement
